Shandong Buchang Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio
Shandong Buchang Pharmaceuticals Co Ltd cash flow-to-debt ratio. Shandong Buchang Pharmaceuticals Co Ltd (603858) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-145.26 Million could theoretically repay 0% of its total liabilities (CN¥9.50 Billion) in one year. Check Shandong Buchang Pharmaceuticals Co Ltd (603858) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Buchang Pharmaceuticals Co Ltd (2011–2024)
Cash flow-to-debt ratio of Shandong Buchang Pharmaceuticals Co Ltd from 2011 to 2024. Historical debt coverage capacity for Shandong Buchang Pharmaceuticals Co Ltd across 14 annual periods. Check 603858 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Shandong Buchang Pharmaceuticals Co Ltd Cash Flow-to-Debt Ratio by Year (2011–2024)
Shandong Buchang Pharmaceuticals Co Ltd cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Shandong Buchang Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Shandong Buchang Pharmaceuticals Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥939.95 Million | CN¥9.52 Billion | ▲ +672.0% |
| 2023 | -0.02x | CN¥-164.26 Million | CN¥9.52 Billion | ▼ -106.1% |
| 2022 | 0.28x | CN¥2.76 Billion | CN¥9.68 Billion | ▲ +105.6% |
| 2021 | 0.14x | CN¥1.32 Billion | CN¥9.54 Billion | ▼ -35.8% |
| 2020 | 0.22x | CN¥1.96 Billion | CN¥9.08 Billion | ▼ -39.1% |
| 2019 | 0.35x | CN¥2.62 Billion | CN¥7.40 Billion | ▲ +6.5% |
| 2018 | 0.33x | CN¥2.05 Billion | CN¥6.17 Billion | ▲ +1.3% |
| 2017 | 0.33x | CN¥1.96 Billion | CN¥5.98 Billion | ▲ +17.2% |
| 2016 | 0.28x | CN¥1.67 Billion | CN¥5.96 Billion | ▲ +12.3% |
| 2015 | 0.25x | CN¥2.12 Billion | CN¥8.50 Billion | ▼ -34.8% |
| 2014 | 0.38x | CN¥1.78 Billion | CN¥4.65 Billion | ▼ -8.8% |
| 2013 | 0.42x | CN¥1.11 Billion | CN¥2.66 Billion | ▼ -48.8% |
| 2012 | 0.82x | CN¥1.35 Billion | CN¥1.65 Billion | ▼ -13.4% |
| 2011 | 0.95x | CN¥1.55 Billion | CN¥1.64 Billion | — |